Charles Centro Oftalmológico

Charles Centro Oftalmológico is a private ophthalmology clinic network in Buenos Aires, Argentina, founded by Dr. Daniel Charles and operating as Centro Oftalmológico Dr. Charles S.A. The organization provides commercial eye-care services including cataract, cornea, retina, glaucoma, refractive surgery, ocular trauma, and transplant-related ophthalmic procedures. It also runs a residency and clinical research operation, and has served as a site for retina-focused clinical trials, including an age-related macular degeneration study sponsored by 4D Molecular Therapeutics. Publicly available descriptions indicate the center has participated in advanced retinal treatments, including RPE65 gene therapy administration for inherited retinal disease. Overall, it appears to be a specialized ophthalmology care provider and research center rather than a drug-development biotech company.